ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis
BMC Cancer
◽
10.1186/s12885-018-4091-5
◽
2018
◽
Vol 18
(1)
◽
Author(s):
Lin Yang
◽
Anna Alyasova
◽
Dingwei Ye
◽
Antonia Ridolfi
◽
Luca Dezzani
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Asian Population
◽
Second Line
◽
Phase 2
◽
Phase 2 Trial
◽
Multicenter Phase
Download Full-text
Related Documents
Cited By
References
239O RECORD-4: Multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis
Annals of Oncology
◽
10.1093/annonc/mdv524.04
◽
2015
◽
Vol 26
◽
pp. ix71
Author(s):
L. Yang
◽
A. Alyasova
◽
D. Ye
◽
A. Karpenko
◽
H. Li
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Asian Population
◽
Second Line
◽
Phase 2
◽
Phase 2 Trial
◽
Multicenter Phase
Download Full-text
2634 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis
European Journal of Cancer
◽
10.1016/s0959-8049(16)31451-4
◽
2015
◽
Vol 51
◽
pp. S524
Author(s):
L. Yang
◽
A. Alyasova
◽
D. Ye
◽
A. Karpenko
◽
H. Li
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Asian Population
◽
Second Line
◽
Phase 2
◽
Phase 2 Trial
◽
Multicenter Phase
Download Full-text
2620 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis
European Journal of Cancer
◽
10.1016/s0959-8049(16)31438-1
◽
2015
◽
Vol 51
◽
pp. S518-S519
Author(s):
B. Alekseev
◽
L. Yang
◽
A. Alyasova
◽
D. Ye
◽
A. Karpenko
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Second Line
◽
Phase 2
◽
Phase 2 Trial
◽
Multicenter Phase
◽
Anti Vegf
Download Full-text
Camrelizumab plus famitinib in patients with advanced or metastatic renal cell carcinoma: data from an open-label, multicenter phase 2 basket study
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-21-1698
◽
2021
◽
pp. clincanres.1698.2021
Author(s):
Yuan-Yuan Qu
◽
Hai-Liang Zhang
◽
Hongqian Guo
◽
Hong Luo
◽
Qing Zou
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase 2
◽
Open Label
◽
Multicenter Phase
Download Full-text
Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma. Michaelson MD, McKay RR, Werner L, Atkins MB, Van Allen EM, Olivier KM, Song J, Signoretti S, McDermott DF, Choueiri TK.Cancer. 2015 Oct 1;121(19):3435-43. [Epub 2015 Jun 8]. doi: 10.1002/cncr.29503.
Urologic Oncology Seminars and Original Investigations
◽
10.1016/j.urolonc.2016.12.023
◽
2017
◽
Vol 35
(3)
◽
pp. 117-118
◽
Cited By ~ 2
Author(s):
Raman Jay
◽
RR McKay
◽
L Werner
◽
MB Atkins
◽
EM Van Allen
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase 2
◽
Poor Risk
◽
Phase 2 Trial
Download Full-text
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial
The Lancet Oncology
◽
10.1016/s1470-2045(16)30196-6
◽
2016
◽
Vol 17
(9)
◽
pp. 1317-1324
◽
Cited By ~ 93
Author(s):
Brian I Rini
◽
Tanya B Dorff
◽
Paul Elson
◽
Cristina Suarez Rodriguez
◽
Dale Shepard
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Active Surveillance
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase 2
◽
Phase 2 Trial
◽
Prospective Phase
Download Full-text
4510 POSTER A phase 2 trial of sunitinib in bevacizumab-refractory metastatic renal cell carcinoma (mRCC): updated results and analysis of circulating biomarkers
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(07)71141-2
◽
2007
◽
Vol 5
(4)
◽
pp. 301
◽
Cited By ~ 1
Author(s):
T.E. Hutson
◽
D.J. George
◽
M.D. Michaelson
◽
J.E. Rosenberg
◽
R.M. Bukowski
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase 2
◽
Circulating Biomarkers
◽
Phase 2 Trial
Download Full-text
Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial
The Lancet Oncology
◽
10.1016/s1470-2045(13)70464-9
◽
2013
◽
Vol 14
(12)
◽
pp. 1233-1242
◽
Cited By ~ 157
Author(s):
Brian I Rini
◽
Bohuslav Melichar
◽
Takeshi Ueda
◽
Viktor Grünwald
◽
Mayer N Fishman
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Dose Titration
◽
Phase 2
◽
First Line
◽
Double Blind
◽
Phase 2 Trial
Download Full-text
SU011248, a novel tyrosine kinase inhibitor, shows antitumor activity in second-line therapy for patients with metastatic renal cell carcinoma: Results of a phase 2 trial
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.4500
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 4500-4500
◽
Cited By ~ 23
Author(s):
R. J. Motzer
◽
B. I. Rini
◽
M. D. Michaelson
◽
B. G. Redman
◽
G. R. Hudes
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Antitumor Activity
◽
Cell Carcinoma
◽
Renal Cell
◽
Kinase Inhibitor
◽
Second Line
◽
Phase 2
◽
Second Line Therapy
◽
Phase 2 Trial
◽
Line Therapy
Download Full-text
SU011248, a novel tyrosine kinase inhibitor, shows antitumor activity in second-line therapy for patients with metastatic renal cell carcinoma: Results of a phase 2 trial
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.4500
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 4500-4500
◽
Cited By ~ 5
Author(s):
R. J. Motzer
◽
B. I. Rini
◽
M. D. Michaelson
◽
B. G. Redman
◽
G. R. Hudes
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Antitumor Activity
◽
Cell Carcinoma
◽
Renal Cell
◽
Kinase Inhibitor
◽
Second Line
◽
Phase 2
◽
Second Line Therapy
◽
Phase 2 Trial
◽
Line Therapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close